---
title: "TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291011046.md"
description: "TherapeuticsMD Inc. (TXMD) shares rose 3.94% to $2.11 on Friday, marking three consecutive days of gains despite a broader market decline. However, the stock underperformed compared to competitor AbbVie, which gained 4.20%. Trading volume exceeded its 50-day average, and TXMD remains 28.47% below its 52-week high."
datetime: "2026-06-26T21:29:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291011046.md)
  - [en](https://longbridge.com/en/news/291011046.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291011046.md)
---

# TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) advanced 3.94% to $2.11 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.24% to 25,297.62 and Dow Jones Industrial Average falling 0.09% to 51,876.11.

This was the stock's third consecutive day of gains.

TherapeuticsMD Inc. closed 28.47% short of its 52-week high of $2.95, which the company reached on January 27th.

The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. (ABBV) rose 4.20% to $253.35.

Trading volume (50,895) eclipsed its 50-day average volume of 39,697.

Data source: Dow Jones Market Data, FactSet. Data compiled June 26, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-26-26 1729ET

### Related Stocks

- [TXMD.US](https://longbridge.com/en/quote/TXMD.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [TherapeuticsMD Q2 FY26 laba bersih turun ke US$ 164.000; revenue lisensi turun ke US$ 864.000](https://longbridge.com/en/news/295572651.md)
- [Synergy Asset Management LLC Grows Stock Position in AbbVie Inc. $ABBV](https://longbridge.com/en/news/296018925.md)
- [Plato Investment Management Ltd Invests $1.49 Million in Biogen Inc. $BIIB](https://longbridge.com/en/news/296206286.md)
- [Cornerstone Capital Inc. Takes Position in Cisco Systems, Inc. $CSCO](https://longbridge.com/en/news/295995972.md)
- [293,524 Shares in GFL Environmental Inc. $GFL Bought by S&CO Inc.](https://longbridge.com/en/news/296021664.md)